Information:
Error:
ID
34333
Description
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01492127
Link
https://clinicaltrials.gov/show/NCT01492127
Keywords
Versions (1)
- 1/16/19 1/16/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 16, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatocellular Carcinoma NCT01492127
Eligibility Hepatocellular Carcinoma NCT01492127
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT01492127
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
cirrhotic patients with hepatocellular carcinoma proven by histological examination of a biopsy specimen, eligible for curative treatment (radiofrequency, surgical resection, liver transplantation)
boolean
ID.2
Item
patient able to give informed consent
boolean
ID.3
Item
patient with social security coverage
boolean
ID.4
Item
secondary liver tumors
boolean
ID.5
Item
non hepatocellular carcinoma primary liver tumor
boolean
ID.6
Item
hepatocellular carcinoma without cirrhosis
boolean
ID.7
Item
patients with hepatocellular carcinoma and cirrhosis not eligible for curative treatment
boolean
ID.8
Item
prisoners
boolean
ID.9
Item
adults under guardianship or curatorship
boolean
ID.10
Item
pregnancy
boolean